» Articles » PMID: 19854497

Regulation of MiR-200 Family MicroRNAs and ZEB Transcription Factors in Ovarian Cancer: Evidence Supporting a Mesothelial-to-epithelial Transition

Overview
Journal Gynecol Oncol
Date 2009 Oct 27
PMID 19854497
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Our objective was to characterize the expression and function of the miR-200 family of microRNAs (miRNA) in ovarian carcinogenesis.

Methods: We used qRT-PCR to examine expression of the miR-200 miRNA family and its predicted targets, the ZEB1 and ZEB2 transcriptional repressors, in primary cultures of normal cells from the surface of the ovary and in a panel of 70 ovarian cancer tissues and 15 ovarian cancer cell lines. We studied the mechanisms of regulation of miR-200 miRNAs and ZEB transcription factors in ovarian cells using 3' UTR luciferase reporters, promoter luciferase reporters and siRNAs.

Results: miR-200 family members are expressed at low or negligible levels in normal ovarian surface cells and substantially increase in expression in ovarian cancer, whereas expression of ZEB1 and ZEB2 shows the opposite pattern. There is reciprocal repression between miR-200 family members and ZEB transcription factors, creating a double negative regulatory feedback loop resembling that reported in other cancer cell types. In contrast to epithelial cells from other sites, expression levels of miR-200 miRNAs and ZEB1/2 in cells from the ovarian surface are more consistent with a mesenchymal cell phenotype, potentially reflecting the mesothelial origin of the ovarian surface.

Conclusion: Analysis of ovarian cancer tissues suggests that ovarian surface cells acquire a more epithelial miR-200-ZEB1/2 phenotype as they undergo transformation, switching from a miR-200 familyLOW and ZEB1/2HIGH state to a miR-200 familyHIGH and ZEB1/2LOW phenotype. Collectively, our data support the mesothelial-to-epithelial (Meso-E-T) model for development of ovarian cancers that arise from ovarian surface cells, as has been proposed previously on the basis of studies of protein markers.

Citing Articles

ZEB2 Gene Pathogenic Variants Across Protein-Coding Regions and Impact on Clinical Manifestations: A Review.

Hossain W, St Peter C, Lovell S, Rafi S, Butler M Int J Mol Sci. 2025; 26(3).

PMID: 39941075 PMC: 11818587. DOI: 10.3390/ijms26031307.


Unleashing the potential of extracellular vesicles for ulcerative colitis and Crohn's disease therapy.

Njoku G, Forkan C, Soltysik F, Nejsum P, Pociot F, Yarani R Bioact Mater. 2024; 45:41-57.

PMID: 39610953 PMC: 11602541. DOI: 10.1016/j.bioactmat.2024.11.004.


Current strategies for early epithelial ovarian cancer detection using miRNA as a potential tool.

Bhadra M, Sachan M, Nara S Front Mol Biosci. 2024; 11:1361601.

PMID: 38690293 PMC: 11058280. DOI: 10.3389/fmolb.2024.1361601.


MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer.

Miglietta S, Girolimetti G, Marchio L, Sollazzo M, Laprovitera N, Coluccelli S Noncoding RNA. 2022; 8(5).

PMID: 36287116 PMC: 9611163. DOI: 10.3390/ncrna8050064.


Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective.

Pal A, Sharma P, Zia A, Siwan D, Nandave D, Nandave M Pathophysiology. 2022; 29(2):200-222.

PMID: 35736645 PMC: 9230911. DOI: 10.3390/pathophysiology29020017.


References
1.
Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M . DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene. 2005; 24(14):2375-85. DOI: 10.1038/sj.onc.1208429. View

2.
Riera J, Longmate J, Battifora H . The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval. Am J Surg Pathol. 1997; 21(12):1409-19. DOI: 10.1097/00000478-199712000-00003. View

3.
Moustakas A, Heldin C . Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 2007; 98(10):1512-20. PMC: 11158989. DOI: 10.1111/j.1349-7006.2007.00550.x. View

4.
Hurteau G, Carlson J, Spivack S, Brock G . Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 2007; 67(17):7972-6. DOI: 10.1158/0008-5472.CAN-07-1058. View

5.
Iorio M, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P . MicroRNA signatures in human ovarian cancer. Cancer Res. 2007; 67(18):8699-707. DOI: 10.1158/0008-5472.CAN-07-1936. View